Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2011, Article ID 810939, 7 pages
http://dx.doi.org/10.1155/2011/810939
Review Article

Toll-Like Receptors Signaling Contributes to Immunopathogenesis of HBV Infection

Division of Gastroenterology, Tohoku University Hospital, 1-1 Seiryo-Machi, Aoba-ku, Miyagi, Sendai City 980-8574, Japan

Received 8 March 2011; Revised 12 October 2011; Accepted 12 October 2011

Academic Editor: Cataldo Doria

Copyright © 2011 Yasuteru Kondo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Tiollais, C. Pourcel, and A. Dejean, “The hepatitis B virus,” Nature, vol. 317, no. 6037, pp. 489–495, 1985. View at Google Scholar · View at Scopus
  2. C. L. Lai, V. Ratziu, M. F. Yuen, and T. Poynard, “Viral hepatitis B,” Lancet, vol. 362, no. 9401, pp. 2089–2094, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. F. V. Chisari and C. Ferrari, “Hepatitis B virus immunopathogenesis,” Annual Review of Immunology, vol. 13, pp. 29–60, 1995. View at Google Scholar · View at Scopus
  4. D. Kägi, B. Ledermann, K. Bürki, R. M. Zinkernagel, and H. Hengartner, “Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo,” Annual Review of Immunology, vol. 14, pp. 207–232, 1996. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Reignat, G. J. M. Webster, D. Brown et al., “Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection,” Journal of Experimental Medicine, vol. 195, no. 9, pp. 1089–1101, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. J. L. Baron, L. Gardiner, S. Nishimura, K. Shinkai, R. Locksley, and D. Ganem, “Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection,” Immunity, vol. 16, no. 4, pp. 583–594, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Bonorino, M. Ramzan, X. Camous et al., “Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C,” Journal of Hepatology, vol. 51, no. 3, pp. 458–467, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Kakimi, L. G. Guidotti, Y. Koezuka, and F. V. Chisari, “Natural killer T cell activation inhibits hepatitis B virus replication in vivo,” Journal of Experimental Medicine, vol. 192, no. 7, pp. 921–930, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Ju, N. Hou, J. Meng et al., “T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B,” Journal of Hepatology, vol. 52, no. 3, pp. 322–329, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. P. T. F. Kennedy, A. J. Gehring, A. Nowbath et al., “The expression and function of NKG2D molecule on intrahepatic CD8+ T cells in chronic viral hepatitis,” Journal of Viral Hepatitis, vol. 15, no. 12, pp. 901–909, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Kondo, S. Asabe, K. Kobayashi et al., “Recovery of functional cytotoxic T lymphocytes during lamivudine therapy by acquiring multi-specificity,” Journal of Medical Virology, vol. 74, no. 3, pp. 425–433, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Boni, A. Penna, A. Bertoletti et al., “Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B,” Journal of Hepatology, vol. 39, no. 4, pp. 595–605, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Kondo, K. Kobayashi, Y. Ueno et al., “Mechanism of T cell hyporesponsiveness to HBcAg is associated with regulatory T cells in chronic hepatitis B,” World Journal of Gastroenterology, vol. 12, no. 27, pp. 4310–4317, 2006. View at Google Scholar · View at Scopus
  14. Y. Kondo, Y. Ueno, K. Kobayashi et al., “Hepatitis B virus replication could enhance regulatory T cell activity by producing soluble heat shock protein 60 from hepatocytes,” Journal of Infectious Diseases, vol. 202, no. 2, pp. 202–213, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Cooper, G. Tal, O. Lider, and Y. Shaul, “Cytokine induction by the hepatitis B virus capsid in macrophages is facilitated by membrane heparan sulfate and involves TLR2,” Journal of Immunology, vol. 175, no. 5, pp. 3165–3176, 2005. View at Google Scholar · View at Scopus
  16. S. Akira, S. Uematsu, and O. Takeuchi, “Pathogen recognition and innate immunity,” Cell, vol. 124, no. 4, pp. 783–801, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. K. MacHida, “TLRs, alcohol, HCV, and tumorigenesis,” Gastroenterology Research and Practice, vol. 2010, Article ID 518674, 8 pages, 2010. View at Publisher · View at Google Scholar
  18. T. Saito, D. M. Owen, F. Jiang, J. Marcotrigiano, and M. Gale, “Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA,” Nature, vol. 454, no. 7203, pp. 523–527, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Visvanathan, N. A. Skinner, A. J. V. Thompson et al., “Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein,” Hepatology, vol. 45, no. 1, pp. 102–110, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Lang, C. Lo, N. Skinner, S. Locarnini, K. Visvanathan, and A. Mansell, “The Hepatitis B e antigen (HBeAg) targets and suppresses activation of the Toll-like receptor signaling pathway,” Journal of Hepatology, vol. 55, no. 4, pp. 762–769, 2011. View at Publisher · View at Google Scholar
  21. S. Yu, J. Chen, M. Wu, H. Chen, N. Kato, and Z. Yuan, “Hepatitis B virus polymerase inhibits RIG-I- and toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1/IKKε and DDX3,” Journal of General Virology, vol. 91, no. 8, pp. 2080–2090, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Wu, Z. Meng, M. Jiang et al., “Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells,” Hepatology, vol. 49, no. 4, pp. 1132–1140, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Kumar, S. Y. Jung, A. J. Hodgson, C. R. Madden, J. Qin, and B. L. Slagle, “Hepatitis B virus regulatory HBx protein binds to adaptor protein IPS-1 and inhibits the activation of beta interferon,” Journal of Virology, vol. 85, no. 2, pp. 987–995, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. S. M. Riordan, N. Skinner, J. Kurtovic, S. Locarnini, and K. Visvanathan, “Reduced expression of Toll-like receptor 2 on peripheral monocytes in patients with chronic hepatitis B,” Clinical and Vaccine Immunology, vol. 13, no. 8, pp. 972–974, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Tavakoli, I. Mederacke, S. Herzog-Hauff et al., “Peripheral blood dendritic cells are phenotypically and functionally intact in chronic hepatitis B virus (HBV) infection,” Clinical and Experimental Immunology, vol. 151, no. 1, pp. 61–70, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. N. Li, Q. Li, Z. Qian, Y. Zhang, M. Chen, and G. Shi, “Impaired TLR3/IFN-β signaling in monocyte-derived dendritic cells from patients with acute-on-chronic hepatitis B liver failure: relevance to the severity of liver damage,” Biochemical and Biophysical Research Communications, vol. 390, no. 3, pp. 630–635, 2009. View at Publisher · View at Google Scholar
  27. Y. Zhang, J. Q. Lian, C. X. Huang et al., “Overexpression of Toll-like receptor 2/4 on monocytes modulates the activities of CD4+CD25+ regulatory T cells in chronic hepatitis B virus infection,” Virology, vol. 397, no. 1, pp. 34–42, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. P. A. Wentworth, E. Celis, C. Crimi et al., “In vitro induction of primary, antigen-specific CTL from human peripheral blood mononuclear cells stimulated with synthetic peptides,” Molecular Immunology, vol. 32, no. 9, pp. 603–612, 1995. View at Publisher · View at Google Scholar · View at Scopus
  29. B. Rehermann, C. Pasquinelli, S. M. Mosier, and F. V. Chisari, “Hepatitis B virus (HBV) sequence variation in cytotoxic T lymphocyte epitopes is not common in patients with chronic HBV infection,” Journal of Clinical Investigation, vol. 96, no. 3, pp. 1527–1534, 1995. View at Google Scholar · View at Scopus
  30. Y. Kondo, K. Kobayashi, S. Asabe et al., “Vigorous response of cytotoxic T lymphocytes associated with systemic activation of CD8+ T lymphocytes in fulminant hepatitis B,” Liver International, vol. 24, no. 6, pp. 561–567, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Frelin, T. Wahlström, A. E. Tucker et al., “A mechanism to explain the selection of the hepatitis e antigen-negative mutant during chronic hepatitis B virus infection,” Journal of Virology, vol. 83, no. 3, pp. 1379–1392, 2009. View at Publisher · View at Google Scholar
  32. H. Maier, M. Isogawa, G. J. Freeman, and F. V. Chisari, “PD-1:PD-L1 interactions contribute to the functional suppression of virus-specific CD8+ T lymphocytes in the liver,” Journal of Immunology, vol. 178, no. 5, pp. 2714–2720, 2007. View at Google Scholar · View at Scopus
  33. F. V. Chisari and C. Ferrari, “Hepatitis B virus immunopathology,” Springer Seminars in Immunopathology, vol. 17, no. 2-3, pp. 261–281, 1995. View at Google Scholar · View at Scopus
  34. J. P. Wang, Y. Zhang, X. Wei et al., “Circulating toll-like receptor (TLR) 2, TLR4, and regulatory T cells in patients with chronic hepatitis C,” APMIS, vol. 118, no. 4, pp. 261–270, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Q. Lian, X. Q. Wang, Y. Zhang, C. X. Huang, and X. F. Bai, “Correlation of circulating TLR2/4 expression with CD3+/4 +/8+ T cells and treg cells in HBV-related liver cirrhosis,” Viral Immunology, vol. 22, no. 5, pp. 301–308, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. J. N. Stoop, R. G. Van Der Molen, C. C. Baan et al., “Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection,” Hepatology, vol. 41, no. 4, pp. 771–778, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. X. P. Nan, Y. Zhang, H. T. Yu et al., “Circulating CD4+CD25high regulatory T cells and expression of PD-1 and BTLA on CD4+ T cells in patients with chronic hepatitis B virus infection,” Viral Immunology, vol. 23, no. 1, pp. 63–70, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. X. Li, Y. Chen, Z. Ma, B. Ye, W. Wu, and L. Li, “Effect of regulatory T cells and adherent cells on the expansion of HBcAg-specific CD8+ T cells in patients with chronic hepatitis B virus infection,” Cellular Immunology, vol. 264, no. 1, pp. 42–46, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. J. Li, W. Wu, G. Peng et al., “HBcAg induces interleukin-10 production, inhibiting HBcAg-specific Th17 responses in chronic hepatitis B patients,” Immunology and Cell Biology, vol. 88, no. 8, pp. 834–841, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. G. Peng, S. Li, W. Wu, Z. Sun, Y. Chen, and Z. Chen, “Circulating CD4+ CD25+ regulatory T cells correlate with chronic hepatitis B infection,” Immunology, vol. 123, no. 1, pp. 57–65, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. G. Yang, A. Liu, Q. Xie et al., “Association of CD4+CD25+Foxp3+ regulatory T cells with chronic activity and viral clearance in patients with hepatitis B,” International Immunology, vol. 19, no. 2, pp. 133–140, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Zanin-Zhorov, L. Cahalon, G. Tal, R. Margalit, O. Lider, and I. R. Cohen, “Heat shock protein 60 enhances CD4+CD25+ regulatory T cell function via innate TLR2 signaling,” Journal of Clinical Investigation, vol. 116, no. 7, pp. 2022–2032, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. B. Schaub, M. Campo, H. He et al., “Neonatal immune responses to TLR2 stimulation: influence of maternal atopy on Foxp3 and IL-10 expression,” Respiratory Research, vol. 7, article 40, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. D. Kabelitz, D. Wesch, and H. H. Oberg, “Regulation of regulatory T cells: role of dendritic cells and toll-like receptors,” Critical Reviews in Immunology, vol. 26, no. 4, pp. 291–305, 2006. View at Google Scholar · View at Scopus
  45. R. Guan, “Interferon monotherapy in chronic hepatitis B,” Journal of Gastroenterology and Hepatology, vol. 15, pp. E34–E40, 2000. View at Publisher · View at Google Scholar
  46. P. Angus, R. Vaughan, S. Xiong et al., “Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase,” Gastroenterology, vol. 125, no. 2, pp. 292–297, 2003. View at Publisher · View at Google Scholar · View at Scopus
  47. Y.-F. Liaw, N. W.Y. Leung, T.-T. Chang et al., “Effects of extended lamivudine therapy in asian patients with chronic hepatitis B,” Gastroenterology, vol. 119, no. 1, pp. 172–180, 2000. View at Google Scholar
  48. R. S. Ross, S. Viazov, and M. Roggendorf, “Clinical and immunological efficacy of intradermal vaccine plus lamivudine with or without interleukin-2 in patients with chronic hepatitis B,” Journal of Medical Virology, vol. 66, no. 4, pp. 452–460, 2002. View at Publisher · View at Google Scholar
  49. Y. Horsmans, T. Berg, J. P. Desager et al., “Isatoribine, an agonist of TLR7, reduces plasma virus concentration in chronic hepatitis C infection,” Hepatology, vol. 42, no. 3, pp. 724–731, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. S. H. Yang, C. G. Lee, S. H. Park et al., “Correlation of antiviral T-cell responses with suppression of viral rebound in chronic hepatitis B carriers: a proof-of-concept study,” Gene Therapy, vol. 13, no. 14, pp. 1110–1117, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. Y. Kondo, Y. Ueno, and T. Shimosegawa, “Immunopathogenesis of hepatitis B persistent infection: implications for immunotherapeutic strategies,” Clinical Journal of Gastroenterology, vol. 2, no. 2, pp. 71–79, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. W. W. Chang, I. J. Su, M. D. Lai, W. T. Chang, W. Huang, and H. Y. Lei, “Toll-like receptor 4 plays an anti-HBV role in a murine model of acute hepatitis B virus expression,” World Journal of Gastroenterology, vol. 11, no. 42, pp. 6631–6637, 2005. View at Google Scholar · View at Scopus
  53. M. Isogawa, M. D. Robek, Y. Furuichi, and F. V. Chisari, “Toll-like receptor signaling inhibits hepatitis B virus replication in vivo,” Journal of Virology, vol. 79, no. 11, pp. 7269–7272, 2005. View at Publisher · View at Google Scholar · View at Scopus
  54. K. Schwarz, T. Storni, V. Manolova et al., “Role of toll-like receptors in costimulating cytotoxic T cell responses,” European Journal of Immunology, vol. 33, no. 6, pp. 1465–1470, 2003. View at Publisher · View at Google Scholar · View at Scopus
  55. J. J. Y. Sung and H. L. Y. Chan, “HBV-ISS (Dynavax),” Current Opinion in Molecular Therapeutics, vol. 8, no. 2, pp. 150–155, 2006. View at Google Scholar · View at Scopus
  56. J. Wu, M. Lu, Z. Meng et al., “Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice,” Hepatology, vol. 46, no. 6, pp. 1769–1778, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. D. Yerly, L. Di Giammarino, F. Bihl, and A. Cerny, “Targets of emerging therapies for viral hepatitis B and C,” Expert Opinion on Therapeutic Targets, vol. 10, no. 6, pp. 833–850, 2006. View at Publisher · View at Google Scholar · View at Scopus